A Lanzon

1.9k citations
11 papers · 1.5k · 1 hit paper · h-index 9

Impact in

    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
  • Oncology top 5%
    • COVID-19 and healthcare impacts
    • Cytokine Signaling Pathways and Interactions

Papers in

    • COVID-19 and healthcare impacts 6
    • Systemic Lupus Erythematosus Research 1
    • Rheumatoid Arthritis Research and Therapies 1

A Lanzon

11 papers receiving 1.4k citations

A Lanzon's Hit Papers

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial 2017 · 415 citations
4150+3+6Years since publication100200300400

Peers

A Lanzon
Comparison fields: 5 of 81
  • Rheumatology 577
  • Oncology 466
  • Immunology 212
  • Infectious Diseases 94
  • General Dentistry 1
Replace Neil A. Accortt with:
Neil A. Accortt United States
Rebecca E. Sadun United States
Silvia Dehler Switzerland
Pavel Napalkov United States
Despina Michailidou United States
Eslam Al‐Abadi United Kingdom
Sivia Lapidus United States
Evangelos Xynos Greece
Elsa F Mateus United Kingdom
Ourania Koukoura Greece
A Lanzon relative to Neil A. Accortt United States Neil A. Accortt's profile →
Citations per field
00.5×2×2.7×
Neil A. Accortt · 1×
Citations per year

Countries citing papers authored by A Lanzon

Since Specialization
Citations

This map shows the geographic impact of A Lanzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Lanzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Lanzon more than expected).

Fields of papers citing papers by A Lanzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Lanzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Lanzon. The network helps show where A Lanzon may publish in the future.

Co-authors

The 11 scholars most cited alongside A Lanzon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A Lanzon Line = papers co-authored together A Lanzon links everyone, so they are left out of the graph.

All Works

11 of 11 papers shown
#Work
1
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Hit paper breakdown →
2017415
2 2016239
3 2018231
4 2021218
5 2020170
6 202098
7 202056
8 202244
9 202126
10
Fallopian tube carcinoma: incidental finding during surgery for acute pelvic inflammatory disease--case report.
20066
11
Buschke-Lowenstein tumor and pregnancy: a case report.
20073

About A Lanzon

A Lanzon is a scholar working on Oncology, Rheumatology, Reproductive Medicine, Infectious Diseases and Immunology, having authored 11 papers that have together received 1.5k indexed citations. Recurring topics across this work include COVID-19 and healthcare impacts (6 papers), Cervical Cancer and HPV Research (1 paper), SARS-CoV-2 detection and testing (1 paper), COVID-19 Clinical Research Studies (1 paper), Ovarian cancer diagnosis and treatment (1 paper), Systemic Lupus Erythematosus Research (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper) and Biosimilars and Bioanalytical Methods (1 paper). The work is most often cited by research in Rheumatology (577 citations), Oncology (466 citations), Immunology (212 citations), Infectious Diseases (94 citations) and General Dentistry (1 citation). A Lanzon has collaborated with scholars based in France, United Kingdom and Spain. Frequent co-authors include Dae‐Hyun Yoo, Won Park, Suyeon Kim, Janusz Jaworski, Edgar Ramiterre, Nenad Prodanović, Asta Baranauskaitė, Piotr Wiland, Carlos Abud‐Mendoza and HoUng Kim. Their work appears in journals such as British journal of surgery, The Lancet, Journal of Clinical Oncology, The Lancet Oncology and American Journal of Obstetrics and Gynecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact